drugset / Trial / NCT03624283

Interventions for Residual Dizziness After Successful Repositioning Maneuvers in Patients With BPPV

NCT03624283

RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the effect of vestibular rehabilitation, with or without medication, on resolving residual dizziness after successful repositioning maneuvers in patients with benign paroxysmal positional.

Timeline

Start
2018-09-01
Primary completion
2019-12-31
Completion
2020-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Betahistine Small molecule 12 mg

Indications